The story of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the healthcare arena . Despite its initial success and impact of vast in earnings , the https://cyberbookmarking.com/story21530568/copyright-s-drug-and-the-pharmaceutical-industry-a-dangerous-prospect